Analysts on Wall Street project that Teva Pharmaceutical Industries Ltd. (TEVA) will announce quarterly earnings of $0.63 per share in its forthcoming report, representing an increase of 3.3$4.29 billion, increasing 3% from the same quarter last year.Over the last 30 days, there has been a downward revision of 0.7% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of ...